All In Biotech

Drug Trial Radar · NCT02546700

A Study to Evaluate Safety and Efficacy of Lebrikizumab in Participants With Chronic Obstructive Pulmonary Disease (COPD)

A Phase II, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Lebrikizumab in Patients With Chronic Obstructive Pulmonary Disease and a History of Exacerbations

Last checked: Nov 20, 2026Latest source record: Sep 10, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 309 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

309

Actual

Start

Sep 17, 2015

Primary completion

Nov 25, 2016

Study completion Nov 25, 2016

Sponsor

Lead sponsor
Hoffmann-La RocheRoche (Genentech) (RHHBY)
Sponsor type
Industry
First posted
Sep 11, 2015

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
Who can join
All sexes, from 40 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Phase II, randomized, double-blind, placebo-controlled, parallel-group clinical trial of lebrikizumab in participants with COPD and a history of exacerbations who are treated with inhaled corticosteroid (ICS) and at least one long-acting bronchodilator inhaler medication. This study will be conducted to assess the safety, efficacy, and patient-reported outcome (PRO) measures.

Conditions

  • Chronic Obstructive Pulmonary Disease

Interventions

  • LebrikizumabDrug

    Lebrikizumab 125 milligrams (mg) will be administered subcutaneously once in every 4 weeks.

  • PlaceboDrug

    Matching placebo will be administered subcutaneously once in every 4 weeks.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change From Baseline in Pre-bronchodilator Forced Expiratory Volume in One Second (FEV1) at Week 12Time frame: Baseline, Week 12

Locations

63 sites in 9 countries. Site status is shown where the registry gives one.

  • Achieve Clinical Research, LLC

    Birmingham, Alabama

  • California Medical Research Associates, Inc.

    Northridge, California

  • Palmtree Clinical research Inc

    Palm Springs, California

  • Finlay Medical Research

    Miami, Florida

  • Progressive Medical Research

    Port Orange, Florida

  • Columbus Regional Research Institute

    Columbus, Georgia

  • Southeast Regional Res Group

    Savannah, Georgia

  • Centex Studies

    Lake Charles, Louisiana

  • The Clinical Research Ctr

    St Louis, Missouri

  • Comprehensive Clinical Research Inc.

    Berlin, New Jersey

  • ISA Clinical Research

    Jamaica, New York

  • Gastonia Pharmaceutical Research

    Gastonia, North Carolina

  • Clinical Research Inst. of Southern Oregon, Pc

    Medford, Oregon

  • S. Carolina Pharmaceutical Research

    Spartanburg, South Carolina

  • Baylor College of Medicine; Ben Taub Hospital- Guntupalli

    Houston, Texas

  • Centex Studies

    Houston, Texas

  • Western Washington Medical Group

    Everett, Washington

  • Premier Clinical Research

    Spokane, Washington

  • MultiCare Health Center of Washington

    Tacoma, Washington

  • Centro Médico Dra de Salvo

    Buenos Aires, Argentina

  • Instituto Ave Pulmo

    Mar del Plata, Argentina

  • Centro Respiratorio Quilmes

    Quilmes, Argentina

  • Investigaciones en Patologias Respiratorias

    San Miguel de Tucumán, Argentina

  • Instituto Del Buen Aire

    Santa Fe, Argentina

  • Specialized Hospital For Active Treatment of Pneumophthisiatric Diseases; Dept of Pneumonology

    Rousse, Bulgaria

  • MHC - Sofia, EOOD

    Sofia, Bulgaria

  • Fifth MHAT - Sofia EAD

    Sofia, Bulgaria

  • National Multiprofile Transport Hospital Tzar Boris Ill; Clinic of Internal Diseases

    Sofia, Bulgaria

  • Medical Center "Nov Rehabilitatsionen Tsentar", EOOD

    Stara Zagora, Bulgaria

  • Medical Center Tara OOD

    Veliko Tarnovo, Bulgaria

  • McMaster University Medical Centre

    Hamilton, Ontario, Canada

  • St. Joseph's Healthcare Hamilton

    Hamilton, Ontario, Canada

  • Inspiration Research

    Toronto, Ontario, Canada

  • Hvidovre Hospital, Lungemedicinsk Afdeling

    Hvidovre, Denmark

  • Lungemedicinsk afd. L, Bispebjerg Hospital

    København NV, Denmark

  • Odense Universitetshospital, Lungemedicinsk Forskningsenhed

    Odense C, Denmark

  • Dr. Kenessey Albert Korhaz Es Rendelointezet; Tudoosztaly (Pulmonolgy Dept )

    Balassagyarmat, Hungary

  • Petz Aladar Megyei Oktato Korhaz

    Győr, Hungary

  • Selye János Kórház és Rendel?intézet; Allergológiai Szakrendelés

    Komárom, Hungary

  • Matrai Állami Gyógyintézet ; Bronchológia

    Mátraháza, Hungary

Showing 40 of 63 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.